Answers are grounded in this paper and cite their sources.
CARM1 and PI3K inhibition shows synergistic anti-growth effects in triple-negative breast cancer cell lines, suggesting a novel therapeutic approach.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: